Prostate Cancer - Results from #25000

Management of older men with clinically localized prostate cancer: The significance of advanced age and comorbidity - Abstract October 9, 2012

Targeting the androgen receptor signalling axis in castration-resistant prostate cancer (CRPC) - Abstract October 9, 2012

Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: A multi-arm multi-stage randomized controlled trial - Abstract October 8, 2012

Exclusive image guided IMRT vs. radical prostatectomy followed by postoperative IMRT for localized prostate cancer: A matched-pair analysis based on risk-groups - Abstract October 8, 2012

Outcome following active surveillance of men with screen-detected prostate cancer. Results from the Göteborg randomised population-based prostate cancer screening trial - Abstract October 8, 2012

Neoadjuvant hormonal therapy use and the risk of death in men with prostate cancer treated with brachytherapy who have no or at least a single risk factor for coronary artery disease - Abstra October 8, 2012

Costs of radical prostatectomy for prostate cancer: A systematic review - Abstract October 8, 2012

Short-term androgen-deprivation therapy improves prostate cancer-specific mortality in intermediate-risk prostate cancer patients undergoing dose-escalated external beam radiation therapy - Abstract October 8, 2012

Impact of delay after biopsy and post-biopsy haemorrhage on prostate cancer tumour detection using multi-parametric MRI: A multi-reader study - Abstract October 8, 2012

Pre-biopsy magnetic resonance imaging and prostate cancer detection: Comparison of random and MRI-targeted biopsies using three different techniques of MRI-TRUS image registration - Abstract October 8, 2012

Placement of retrievable self-expandable metallic stents with barbs into patients with obstructive prostate cancer - Abstract October 8, 2012

Prostate cancer: Germline prediction for a commonly variable malignancy - Abstract October 5, 2012

Low pretreatment serum total testosterone is associated with a high incidence of Gleason score 8-10 disease in prostatectomy specimens: Data from ethnic Chinese patients with localized prostate cancer - Abstract October 5, 2012

Cognitive problems in patients on androgen deprivation therapy: A qualitative pilot study - Abstract October 5, 2012

Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials - Abstract October 5, 2012

Influence of the number of elongated fiducial markers on the localization accuracy of the prostate - Abstract October 5, 2012

Role of early proctoscopy in predicting late symptomatic proctitis after external radiation therapy for prostate carcinoma - Abstract October 5, 2012

Kilovoltage intrafraction monitoring for prostate intensity modulated arc therapy: First clinical results - Abstract October 5, 2012

First results of endocavity evaluation of the microvascularization of malignant prostate tumors using contrast enhanced ultrasound (CEUS) including perfusion analysis: First results - Abstract October 5, 2012

Efficacy of cetuximab in metastatic castration-resistant prostate cancer might depend on EGFR and PTEN expression: Results from a phase II trial (SAKK 08/07) - Abstract October 5, 2012

Page 1251 of 1453